Desborough Group: Platelet disorders and transfusion
- Nuffield Division of Clinical Laboratory Sciences
The overarching aim of the group is to develop and trial new treatments for platelet disorders and finding alternatives to platelet transfusion.
- This includes trials of reversing antiplatelet drugs in intracerebral haemorrhage
- Optimising treatment of fetal and neonatal alloimmune thrombocytopenia (FNAIT)
- Clinical trials in transfusion medicine and immunohaematology [thrombotic thrombocytopenic purpura (TTP), immune thrombocytopenia (ITP), warm autoimmune haemolytic anaemia (wAIHA), cold agglutinin disease (CAD)]
- Developing the evidence base for platelet transfusion and alternatives to transfusion
Collaborators
- Professor Nikola Sprigg (University of Nottingham)
- Dr Beth Psaila
- Dr Lise Estcourt
- Dr Sue Pavord (University of Oxford)
- Professor Samira Lakhal-Littleton (University of Oxford)
- Dr Alex Bye (University of Reading)
- Susan Brunskill (Systemic Reviews Initiative, NHS Blood and Transplant)